Related Experiment Video
Updated: Nov 12, 2025
07:54
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.4K
Dendrimers based cancer nanotheranostics: An overview.
Vikrant Saluja1, Yachana Mishra2, Vijay Mishra3
1Faculty of Pharmaceutical Sciences, PCTE Group of Institutes, Ludhiana, Punjab, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
International Journal of Pharmaceutics
|March 21, 2021
Summary
Nanotechnology offers advanced nanocarriers for cancer diagnosis and therapy. Dendrimers, a type of nanocarrier, show promise for nanotheranostics, improving cancer treatment precision and monitoring.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Conventional cancer treatment faces challenges with non-specific targeting and therapy monitoring.
- Nanotechnology-derived nanocarriers offer unique properties to improve cancer diagnosis and treatment.
- Nanotheranostics integrates diagnostic and therapeutic functions for enhanced efficacy.
Purpose of the Study:
- To explore the potential of nanocarriers, specifically dendrimers, as nanotheranostic platforms for cancer.
- To highlight how nanotheranostics can overcome biological barriers and improve drug delivery.
- To demonstrate the application of nanotheranostics in targeted drug delivery, imaging, and treatment monitoring.
Main Methods:
- Utilizing nanotechnology-derived nanocarriers for integrated diagnostic and therapeutic applications.
- Designing nanotheranostic platforms to overcome biological barriers and target cancer cells.
- Exploiting dendrimers' unique physicochemical properties, including precise size control and surface functionalization.
Main Results:
- Nanotheranostic platforms can overcome biological barriers and target payloads to specific cancer sites.
- Dendrimers exhibit well-defined structures, monodispersity, and controllable surface functionalization.
- Dendrimer properties ensure reproducible pharmacokinetics, biodistribution, and therapeutic efficacy.
Conclusions:
- Dendrimers represent an advanced nanotheranostic platform with potential to revolutionize oncology.
- Nanotheranostics enables precise drug targeting, image-guided therapy, and treatment response monitoring.
- Exploiting dendrimers for nanotheranostics can lead to improved cancer diagnosis and treatment strategies.
